Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Atherosclerosis
Noninvasive fingertip test to detect early coronary disease is study topic
February 20th, 2005
A noninvasive fingertip test can identify coronary disease at its earliest stages and may provide an easy to use tool for daily clinical practice, according to a recent study published in the Journal of the American College of Cardiology. The Endo-PAT 2000, a system for assessing vascular endothelial dysfunction, an early indicator of atherosclerosis, was developed by Itamar Medical of Caesarea, Israel. Distributed in the United States by Cholestech Corporation (CTEC), it has received clearance from the U.S. Food and Drug Administration (FDA) for use as an aid in the detection of coronary artery endothelial dysfunction. Cholestech expects to...
Source: Medical Letter on the CDC & FDA (2005-02-20)
|
